Intelligent Medicine Acquisition Corp.

NasdaqGM:IQMD Stock Report

Market Cap: US$64.8m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Intelligent Medicine Acquisition Management

Management criteria checks 0/4

Key information

Greg Simon

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.3yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure1.4yrs

Recent management updates

No updates

Recent updates

No updates

CEO

Greg Simon (70 yo)

2.3yrs

Tenure

Mr. Gregory C. Simon, also known as Greg, serves as Member of Palantir Federal Advisory Board at Palantir Technologies Inc. since October 2022. He served as the Chief Executive Officer of Poliwogg Holdings...

Board Members

NamePositionTenureCompensationOwnership
Gregory Simon
CEO, CFO & Director2.3yrsno datano data
Samir Khleif
Principal Advisor & Member of Advisory Committeeno datano datano data
Joseph Schocken
Independent Director1.4yrsno datano data
William Haseltine
Member of Advisory Committeeno datano datano data
Jack Hidary
Independent Chairman of the Board2.2yrsno datano data
Susan Siegel
Member of Advisory Committeeno datano datano data
Usama Fayyad
Member of Advisory Committeeno datano datano data
Peter Knight
Member of Advisory Committeeno datano datano data
Llew Keltner
Member of Advisory Committeeno datano datano data
Patience Marime-Ball
Independent Director1.4yrsno datano data
Geoffrey Shiu Ling
Member of Advisory Committeeno datano datano data
Kavita Patel
Independent Director1.4yrsno datano data

1.4yrs

Average Tenure

63yo

Average Age

Experienced Board: IQMD's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/04/28 06:28
End of Day Share Price 2023/04/26 00:00
Earnings2022/12/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Intelligent Medicine Acquisition Corp. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.